A False Claims Act relator has petitioned the U.S. Supreme Court to revive a lawsuit against drugmaker Takeda Pharmaceuticals North America Inc. (United States ex rel. Nathan v. Takeda Pharm. N. Am.).
Relator Noah Nathan’s petition, filed in May, seeks a reversal of the U.S. Court of Appeals for the Fourth Circuit’s Jan. 11 decision dismissing the case, which alleged the company’s marketing of the drug Kapidex caused false claims to be presented to the government. The appeals court affirmed a federal district court dismissal of the lawsuit for failure to satisfy the heightened pleading standards of Federal ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.